Clinical Trials Directory

Trials / Completed

CompletedNCT01001533

Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation

A Pilot Study to Assess the Ability of Non-invasive Bio-impedance Cardiac Monitoring to Detect and Trend Hemodynamic Variables During Dexmedetomidine (DEX) Sedation in Children for Radiology Procedures

Status
Completed
Phase
Study type
Observational
Enrollment
17 (actual)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
1 Month – 18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate the use of a new FDA-approved non-invasive bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in children undergoing radiology procedures. The purpose of the study is to determine the ability of the ICON monitor to identify the anticipated and documented hemodynamic changes in children which occur in response to Dexmedetomidine sedation. The investigators postulate that if the ICON device can trend hemodynamic changes, if any, during dexmedetomidine (DEX) sedation in children the investigators can delineate changes in cardiac output, stroke volume, and systemic vascular resistance associated with observed changes in heart rate and blood pressure.

Conditions

Timeline

Start date
2009-09-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2009-10-26
Last updated
2017-01-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01001533. Inclusion in this directory is not an endorsement.

Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation (NCT01001533) · Clinical Trials Directory